reported that AIM2 might promote cell proliferation in gastric cancer via the mitogen-activated protein kinase (MAPK) pathway (167), leading us to suspect that AIM2 might also control keratinocyte proliferation by augmenting the Wnt or MAPK pathways. The gene discussed is AIM2; the disease is gastric cancer.